Drug Shortage Report for CARBOLITH
| Report ID | 39127 |
| Drug Identification Number | 02011239 |
| Brand name | CARBOLITH CAPSULES 600MG |
| Common or Proper name | CARBOLITH CAPSULES 600MG |
| Company Name | BAUSCH HEALTH, CANADA INC. |
| Market Status | MARKETED |
| Active Ingredient(s) | LITHIUM CARBONATE |
| Strength(s) | 600MG |
| Dosage form(s) | CAPSULE |
| Route of administration | ORAL |
| Packaging size | na |
| ATC code | N05AN |
| ATC description | ANTIPSYCHOTICS |
| Reason for shortage | Other (Please describe in comments) |
| Anticipated start date | |
| Actual start date | 2018-02-08 |
| Estimated end date | |
| Actual end date | 2018-02-28 |
| Shortage status | Resolved |
| Updated date | 2018-03-01 |
| Company comments | |
| Health Canada comments | |
| Tier 3 Status | No |
| Contact Address | 2150 BOUL. ST-ELZEAR OUEST LAVAL, QUEBEC CANADA H7L 4A8 |
| Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v1 | 2018-02-08 | English | Compare |
| v2 | 2018-02-08 | French | Compare |
| v3 | 2018-02-09 | English | Compare |
| v4 | 2018-03-01 | English | Compare |
Showing 1 to 4 of 4